Our comprehensive molecular analysis examines over 20,000 unique genes and their complex interactions. By harnessing the genetic insights derived from the patient’s tumor tissue sample, we are able to decipher the underlying biological mechanisms that contribute to increased disease risk and progression.
This enhanced understanding of the patient’s disease state allows us to offer more personalized and targeted management approaches.
“Thank you for having this test. It is truly a blessing for patients to have more treatment options.“
“I was overwhelmed with emotions when I discovered that the results from my QGCT report aligned perfectly with the medication my doctor is currently using.“
“This test will significantly benefit more people who have run out of treatments.“
Our genes fundamentally shape our identity and overall health. While DNA serves as the building blocks of our genetic language, it is RNA that transforms these building blocks into actionable instructions that govern our health.
These small yet powerful molecules function dynamically and collaboratively to maintain cellular health. However, disruptions in their behavior can lead to cancerous transformations in cells.
At BYQM, we are committed to analyzing the interactions of patients’ RNA molecules. By doing so, we aim to identify the underlying issues within cancer and ultimately tailor targeted treatments, ensuring a personalized and precise approach to patient care.
We understand that patients have many commitments.
We’ll handle all the work so they don’t have to worry.
Disclaimer: This test has not been cleared or approved by the U.S. Food and Drug Administration (FDA). The use of this test does not guarantee that a patient will be matched to a specific drug treatment.